我武生物：8月21日召开董事会会议

Core Viewpoint - Iwubio announced the convening of its 13th meeting of the 5th Board of Directors on August 21, 2025, to review various proposals, including amendments to existing documents [2] Financial Performance - For the first half of 2025, Iwubio reported that its revenue composition was 99.59% from pharmaceutical manufacturing and 0.41% from other businesses [2]